October 2016 | Certara

Blog

Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug

Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…

CertaraOctober 21, 2016

Press Release

Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan

PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…

CertaraOctober 13, 2016

Press Release

Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’

PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…

CertaraOctober 6, 2016

Publication

Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models

CertaraOctober 5, 2016

Publication

A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion

Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…

CertaraOctober 1, 2016

Publication

Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains

CertaraOctober 1, 2016

© 2025 Certara. All Rights Reserved. | Privacy policy